CARTALAX

This three-amino-acid peptide belongs to the bioregulator family developed by Russian researcher Vladimir Khavinson, specifically targeting cartilage and joint tissue health. Composed of alanine, glutamic acid, and aspartate, it represents part of a broader Russian research program into tissue-specific regulatory peptides that began in the 1980s. Researchers investigating cartilage degeneration and age-related joint changes have shown particular interest in its potential applications.

The peptide appears to work by binding to specific DNA sequences and modulating gene expression patterns within cartilage cells, particularly chondrocytes responsible for maintaining joint tissue. Rather than directly supplying building blocks for cartilage repair, it functions more like a regulatory signal that may help cells remember how to maintain healthy tissue patterns. Think of it as potentially resetting cellular programming related to cartilage maintenance rather than providing raw materials for repair.